Fatal disseminated Kaposi’s sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients
Open Access
- 30 January 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 10 (2) , 295-300
- https://doi.org/10.1002/lt.20058
Abstract
Human herpesvirus 8 (HHV-8) is associated with the development of Kaposi’s sarcoma (KS) and rare lymphoproliferative disorders in immunosuppressed patients. The risk of HHV-8 transmission by liver transplantation and the clinical manifestations of primary infection in this setting have yet to be determined. In order to evaluate this risk, we measured the seroprevalence of HHV-8 among 122 liver donors and their respective recipients before and after transplantation. Molecular methods and immunohistochemical analyses were performed to study the features of HHV-8 infection. Antibodies to HHV-8 were detected in sera of 4 donors before transplantation (3.3%) and of 3 recipients (2.4%). None of the 3 recipients, who were HHV-8 seropositive before transplantation, developed a KS during the follow-up. Four primary HHV-8 infections were detected among the 4 HHV-8 seronegative recipients who received a liver from an HHV-8 positive donor. Among these 4 recipients, 2 particularly immunosuppressed patients developed symptomatic diseases and died a few months after transplantation, harboring disseminated KS and HHV-8 positive lymphoproliferation. In these 2 patients, HHV-8 DNA genome sequences were detectable in peripheral blood mononuclear cells and other tissues with high viremia levels before and at the beginning of HHV-8-related diseases. In conclusion, in liver transplantation recipients, HHV-8 primary infection can be associated with fatal outcome. This study raises the question of screening liver donors for HHV-8—even in low HHV-8 infection prevalence countries—not systematically to exclude the graft but to monitor, clinically and biologically, patients who received a graft from an HHV-8-infected donor. (Liver Transpl 2004;10:295-300.)Keywords
This publication has 23 references indexed in Scilit:
- Rituximab therapy for HIV-associated Castleman diseaseBlood, 2003
- Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, DiseasesClinical Microbiology Reviews, 2002
- Kaposi's Sarcoma Associated with Previous Human Herpesvirus 8 Infection in Heart Transplant RecipientsJournal of Clinical Microbiology, 2002
- Aids-related malignanciesNature Reviews Cancer, 2002
- HUMAN HERPESVIRUS-8 SEROCONVERSIONS AFTER RENAL TRANSPLANTATION1Transplantation, 2001
- Kaposi’s sarcoma in liver transplant recipients: Morphological and clinical descriptionLiver Transplantation, 2001
- Simultaneous Multiorgan Presence of Human Herpesvirus 8 and Restricted Lymphotropism of Epstein‐Barr Virus DNA Sequences in a Human Immunodeficiency Virus–Negative Immunodeficient InfantThe Journal of Infectious Diseases, 2001
- Transmission of Human Herpesvirus 8 Infection from Renal-Transplant Donors to RecipientsNew England Journal of Medicine, 1998
- Exacerbations of Clinical Symptoms in Human Immunodeficiency Virus Typ 1-Infected Patients with Multicentric Castleman's Disease Are Associated with a High Increase in Kaposi's Sarcoma Herpesvirus DNA Load in Peripheral Blood Mononuclear CellsThe Journal of Infectious Diseases, 1997
- Kaposiʼs sarcoma-associated herpesvirus infection prior to onset of Kaposiʼs sarcomaAIDS, 1996